DeepMed Research

University Hospital Geneva Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging

Phase 1

Terminated

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: ferucarbotran (iron-based MRI contrast agent)
Procedure: Islet transplantation
Procedure: Magnetic resonance imaging

First Posted Date: 2007-03-29

Last Posted Date: 2014-12-02

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 5

Registration Number: NCT00453817

Locations: 🇨🇭
Geneva University Hospitals Department of Surgery, Geneva, Switzerland

Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Completed

Conditions: Respiratory Tract Infections
Pulmonary Disease, Chronic Obstructive
Virus Diseases
Lung Diseases, Obstructive

First Posted Date: 2007-03-19

Last Posted Date: 2010-11-04

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 86

Registration Number: NCT00448604

Locations: 🇨🇭
Geneva University Hospital, Geneva, Switzerland

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Phase 2

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Pioglitazone
Drug: Interferon Alfa-2a
Drug: Ribavirin

First Posted Date: 2007-02-09

Last Posted Date: 2015-05-28

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 5

Registration Number: NCT00433069

Locations: 🇨🇭
Service de Gastroentérologie et d'Hépatologie, University Hospital, Geneva, GE, Switzerland

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

Phase 3

Completed

Conditions: Distal (Calf) Deep-vein Thrombosis

Interventions: Drug: Placebo
Drug: nadroparine calcium

First Posted Date: 2007-01-12

Last Posted Date: 2018-05-04

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 260

Registration Number: NCT00421538

Locations: 🇨🇦
Royal University Hospital, Saskatoon, Saskatchewan, Canada
🇫🇷
Montpellier University Hospital, Montpellier, Languedoc, France
🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

and more 4 locations

The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block

Phase 4

Completed

Conditions: Neuromuscular Blockade

Interventions: Drug: Physiologic saline
Drug: Magnesium sulphate

First Posted Date: 2006-12-04

Last Posted Date: 2011-09-19

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 80

Registration Number: NCT00405977

Locations: 🇨🇭
University Hospital of Geneva, Anesthesia Department, Geneva, Canton of Geneva, Switzerland

Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study

Phase 4

Terminated

Conditions: Postoperative Nausea and Vomiting
Postoperative Pain

Interventions: Drug: Saline
Drug: Dexamethasone

First Posted Date: 2006-11-27

Last Posted Date: 2010-08-16

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 215

Registration Number: NCT00403806

Locations: 🇨🇭
University Hospital of Geneva, Anesthesia Department, Geneva, Canton of Geneva, Switzerland

Evaluation of Emergency Triage Using a Computerized Simulator

Not Applicable

Completed

Conditions: Emergencies

First Posted Date: 2006-05-03

Last Posted Date: 2008-06-04

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 150

Registration Number: NCT00321243

Locations: 🇨🇭
Geneva University Hospitals, Geneva, Switzerland

Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation

Conditions: Atrial Fibrillation

First Posted Date: 2006-04-17

Last Posted Date: 2007-04-20

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 180

Registration Number: NCT00315068

Locations: 🇨🇭
Cardiology Division University Hospital, Geneva, Switzerland

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

Terminated

Conditions: Cancer
Venous Thromboembolism

First Posted Date: 2006-03-16

Last Posted Date: 2006-03-16

Lead Sponsor: University Hospital, Geneva

Registration Number: NCT00303407

Locations: 🇨🇭
Center of Continuous Care, chemin de la Savonnière, Collonge-Bellerive (Geneva), Geneva, Switzerland

Procalcitonin-Guided Antimicrobial Discontinuation

Phase 4

Completed

Conditions: Sepsis

First Posted Date: 2005-11-08

Last Posted Date: 2008-07-08

Lead Sponsor: University Hospital, Geneva

Target Recruit Count: 70

Registration Number: NCT00250666

Locations: 🇨🇭
Geneva Universits Hospitals, Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy